Home/Filings/4/0000950170-24-010461
4//SEC Filing

Hopkins Janet Jill 4

Accession 0000950170-24-010461

CIK 0001501796other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:01 PM ET

Size

7.2 KB

Accession

0000950170-24-010461

Insider Transaction Report

Form 4
Period: 2024-02-01
Hopkins Janet Jill
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2024-02-01+28,515163,515 total
  • Award

    Stock Option (Right to Buy)

    2024-02-01+41,48541,485 total
    Exercise: $7.77Exp: 2034-01-31Common Stock (41,485 underlying)
Footnotes (2)
  • [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2025, subject to the Reporting Person's continued service as of each such vesting date.
  • [F2]The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2025 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Documents

1 file

Issuer

Aura Biosciences, Inc.

CIK 0001501796

Entity typeother

Related Parties

1
  • filerCIK 0001997710

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:01 PM ET
Size
7.2 KB